SIDE-BY-SIDE COMPARISON

CompareValence LabsvsCradle

Review features, pricing signals, strengths, and trade-offs before choosing.

Generated from current catalog profiles Catalog profile signals Use-case comparison
AI Drug Discovery & Protein/Molecule Design Software

Cradle

SF 7.5

AI protein design for wet labs

Contact sales

Quick decision guide

Choose based on your workflow

Not enough differentiated product data yet to make a strong automatic pick.

Overview

How each tool is described

Valence Labs

Valence Labs is an AI drug discovery research lab backed by Recursion, developing machine learning methods for molecular discovery.

  1. Research focus: It supports R&D acceleration and computational biology rather than guaranteed clinical outcomes, with candidates depending on downstream validation and trials.
  2. Best-fit environment: Computational discovery research teams may benefit most when research-first ML aligns with discovery workflows.
  3. Engagement model: Access runs through pharma partnerships rather than self-service subscriptions, making data requirements, timelines to validated leads, and collaboration structure considerations.
  4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, while the research-facing model should be weighed against packaged software options.

Valence Labs is best assessed as a research partnership whose fit depends on scientific goals, data access, and collaboration requirements.

View full Valence Labs profile

Cradle

Cradle is an AI protein engineering platform for protein engineering and biotech teams, supporting the design and optimization of proteins for research programs.

  1. Research focus: It supports R&D acceleration and computational biology rather than guaranteed clinical outcomes, with candidates still requiring downstream validation and trials.
  2. Best-fit environment: Protein engineering and biotech teams may benefit most when accessible protein design fits established wet-lab workflows and in-house research programs.
  3. Engagement model: Access typically runs through pharma partnerships rather than self-service subscriptions, making collaboration structure, data requirements, and expected timelines to validated leads important buying considerations.
  4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, with value shaped by the depth of internal protein programs.

Cradle is best assessed as an accessible protein design layer whose fit depends on wet-lab integration, in-house expertise, and research objectives.

View full Cradle profile

Side-by-side

Key differences

Criteria
AI Drug Discovery & Protein/Molecule Design SoftwareValence Labs
AI Drug Discovery & Protein/Molecule Design SoftwareCradle
Best for
AI Drug Discovery & Protein/Molecule Design Software
AI Drug Discovery & Protein/Molecule Design Software
Score
7.2/10
7.5/10
Pricing
Contact sales
Contact sales
Category / audience
AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design Software
AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design Software

OVERLAP

Where Valence Labs and Cradle are similar

Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.

5 capabilities5 workflows

Shared capabilities

Capability overlap

  • Target DiscoveryIdentifies potential drug targets from biological data
  • Molecule DesignGenerates and ranks small molecule candidates
  • Protein ModelingPredicts and designs protein structures
  • Knowledge GraphConnects biological and chemical knowledge sources
  • Virtual ScreeningScreens compound libraries against targets

Shared workflows

Workflow overlap

  • Mine literature for research signalsMine biomedical literature for research and target signals.
  • Run virtual screens against targetsRun virtual screening across large compound libraries.
  • Collaborate with pharma partnersCollaborate with pharma partners on discovery programs.

Feature check

Side-by-side feature check

Feature
Valence Labs
Cradle
Partner WorkflowsWorkflows for pharma partner collaborations
-
Literature IntelligenceMines biomedical literature for relevant evidence
-
Target DiscoveryIdentifies potential drug targets from biological data
Molecule DesignGenerates and ranks small molecule candidates
Protein ModelingPredicts and designs protein structures
Knowledge GraphConnects biological and chemical knowledge sources
7 capabilities compared.2 differentiating rows are shown first.

The trade-offs

Pros & cons of each tool

Trade-offs

Valence Labs

Pros
  • Research-first ML for molecular discovery
  • Targets drug discovery needs rather than a generic suite
  • Scales across organization-wide research programs
Cons
  • Research-facing rather than packaged software
Trade-offs

Cradle

Pros
  • Accessible protein design for wet labs
  • Concentrates on drug discovery depth over broad coverage
  • Scales to organization-wide healthcare rollouts
Cons
  • Best value needs in-house protein programs

Shared trade-offs

Catalog data lists these trade-offs for both tools.

Cons
  • Drug success still depends on downstream trials
  • Pricing is sales-led and needs scoping upfront

Final verdict

Best fit depends on your workflow

Catalog verdict · low confidence

Current catalog data shows meaningful overlap between Valence Labs and Cradle. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.

Shared catalog overlap

Valence Labs and Cradle share 10 catalog signals, so the decision should focus on fit rather than broad capability alone.

Differentiators available

Valence Labs has 3 visible decision signals and Cradle has 3.

Score signal

Cradle has the higher SoftFinders Score in the current catalog data.

TRY THEM YOURSELF

See which one fits your workflow

Both tools have their strengths, the best way to decide is to spend a few minutes inside each.